FDA panel backs Apotex's Ferriprox

FDA's Oncologic Drugs Advisory Committee voted 10-2 on Wednesday that Ferriprox deferiprone from Apotex Inc. (Toronto, Ontario) has a favorable benefit-risk profile to treat transfusional iron overloa...